NEA Management Company as of March 31, 2013
Portfolio Holdings for NEA Management Company
NEA Management Company holds 25 positions in its portfolio as reported in the March 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 23.7 | $253M | 12M | 21.96 | |
| Xoom | 10.8 | $115M | 5.1M | 22.84 | |
| Fusion-io | 10.8 | $115M | 7.0M | 16.37 | |
| Clovis Oncology | 9.2 | $98M | 3.4M | 28.67 | |
| Hyperion Therapeutics | 7.0 | $75M | 2.9M | 25.82 | |
| Supernus Pharmaceuticals (SUPN) | 5.6 | $60M | 11M | 5.62 | |
| Millennial Media | 4.9 | $52M | 8.2M | 6.35 | |
| Audience | 4.1 | $44M | 2.9M | 15.25 | |
| Boingo Wireless | 3.3 | $36M | 6.4M | 5.52 | |
| Sunesis Pharmaceuticals | 2.9 | $31M | 5.6M | 5.47 | |
| Lexicon Pharmaceuticals | 2.4 | $26M | 12M | 2.18 | |
| Rigel Pharmaceuticals | 2.1 | $22M | 3.2M | 6.80 | |
| Nektar Therapeutics (NKTR) | 1.9 | $20M | 1.8M | 11.00 | |
| Targacept | 1.8 | $20M | 4.6M | 4.28 | |
| Amicus Therapeutics (FOLD) | 1.7 | $18M | 5.7M | 3.17 | |
| Glu Mobile | 1.7 | $18M | 5.9M | 3.00 | |
| Cadence Pharmaceuticals | 1.3 | $14M | 2.1M | 6.69 | |
| Exelixis (EXEL) | 0.9 | $10M | 2.2M | 4.62 | |
| Transcept Pharmaceuticals | 0.9 | $10M | 2.1M | 4.79 | |
| Alimera Sciences | 0.8 | $8.2M | 2.7M | 3.07 | |
| InterMune | 0.7 | $7.3M | 804k | 9.05 | |
| ArQule | 0.6 | $6.5M | 2.5M | 2.59 | |
| Solta Medical | 0.6 | $6.3M | 2.9M | 2.20 | |
| Zhone Technologies | 0.4 | $4.3M | 4.8M | 0.89 | |
| NeuroMetrix | 0.0 | $141k | 57k | 2.46 |
